Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
nefopam + ketoprofen + paracetamol
- Development stage
- Phase 4
- Lead developer
- Rivo
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
A multimodal analgesic combination used primarily for postoperative pain management. This combination leverages the different mechanisms of action of each component to provide enhanced pain relief while reducing opioid requirements. Clinical studies have shown that this combination significantly reduces morphine consumption and pain scores after surgery compared to dual combinations or single agents.
- Other names
- nefopam + ketoprofen + acetaminophen
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)
Beyond the preview
Go deeper on nefopam + ketoprofen + paracetamol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on nefopam + ketoprofen + paracetamol.